SHANNON JOHN PATRICK JR (See Remarks) purchased 37.9% of their position (100K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $209.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/12/2021ACC: 0001867096-21-000077
Officer· See Remarks
Since Oct 2021
+100K
Net shares
Net buyer
$209.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+40K
Price / share
$2.09
Trade value
$83.50K
% of position
15.2%
11/11/2021
263.83K→303.83K
Common Stock
Direct
Shares
+60K
Price / share
$2.10
Trade value
$126K
% of position
19.7%
11/12/2021
303.83K→363.83K
Total
Net shares
+100K
Net value
$209.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2021 | P · Purchase | +40K | $2.09 | $83.50K | 15.2% | 263.83K | 303.83K |
| Common Stock Direct | 11/12/2021 | P · Purchase | +60K | $2.10 | $126K | 19.7% | 303.83K | 363.83K |
| Total | +100K | $209.50K | ||||||
Derivative Transactions0
No derivative transactions reported